Stefan K. Barta

OncoDaily

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

May, 2025

Stefan K. Barta

May 9, 2025, 12:28 | Science

Aaron Goodman Highlights IL18-Secreting CAR T Therapy for Refractory Lymphoma

Aaron Goodman, Hematologist/Oncologist and an Associate Professor of Medicine at the University of California, shared…

Nov 1, 2024, 17:17 | Blog

Raul Cordoba: Valemetostat for relapsed or refractory peripheral T-cell lymphoma

Raul Cordoba shared on X: "Valemetostat for patients with relapsed or refractory peripheral T-cell lymphoma (VALENTINE-PTCL01):…

Aug 12, 2024, 01:20 | Blog

Using CRISPR technology to enhance CAR-T cells

Patrick Hwu shared on X: "How do we make more effective CAR-T cells? The Marco Ruella…

All: 3 Posts: 1 - 100

'

Francesco Acerbi and Testicular Cancer: The Defender's Fight and Triumphant Return to Football

'

Yvonne Award for Breakthrough Research 2024 Recipient to Time100 Health List

'

Dr Saunthari Somasundaram is the new President-Elect of the NCD Alliance

'

Does Plastic Cause Cancer? Myths and Facts

'

TOPGEAR trial at ESTRO 2025: Preoperative Chemoradiotherapy for Resectable Gastric Cancer

Special Coverage

Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023